XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Stock-Based Compensation
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. reported Stock-Based Compensation of $8.07 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-06-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-06-01
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $250.07K.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $167.75K.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was -$30.32K.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $7.68M.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $8.07M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $250.07K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-01 | $417.82K derived: sum of 2 quarters · filed 2020-06-01 | $387.51K derived: sum of 3 quarters · filed 2020-06-01 | $8.07M 10-K · filed 2020-06-01 |
| 2019-09-30 | $167.75K 10-Q · filed 2019-11-14 | $137.44K derived: sum of 2 quarters · filed 2019-11-14 | $7.82M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$30.32K 10-Q · filed 2019-08-15 | $7.65M 10-Q · filed 2019-11-14 | ||
| 2019-03-31 | $7.68M 10-Q · filed 2019-08-15 |